TIGroup Announces Third Quarter Results, New Growth Initiatives And Medical Advisory Board
08/17/09
BEVERLY HILLS, Calif.-- Tri-Isthmus
Group, Inc. (TIGroup) (OTC BB: TISG), a provider of financial
solutions to the healthcare services industry, announced today results
for the company’s third fiscal quarter ended June 30, 2009. The company
also announced the formation of a new Medical Advisory Board and
completion of a series of growth initiatives including an expansion of
its physician partner base at its Del Mar ambulatory surgical center in
San Diego and completion of its previously announced acquisition of
Chandler Medical Group in Oklahoma.
Business development, management and financing activity highlights
for the quarter were:
- Medical Advisory Board: The company formed a new Medical
Advisory Board headed by Initial members Dr. Harley Liker, Dr. William
Shoemaker, Dr. James Chao and Dr. David Chao. The board was created to
give the company’s physician partners a platform to deliver organized
input into company strategy, industry trends and areas of opportunity
based on their perspectives and experiences in the markets they serve.
The company expects to add three to five additional members during the
next fiscal year.
- Del Mar Expansion: The addition of new physician partners to
the Del Mar surgery center represented another expansion for this
already profitable facility. The new partners have made a fresh
investment in the surgery center and in TIGroup totaling in excess of
$600,000. TIGroup expects a positive contribution to revenue and
EBITDA as a result of the addition of the new partners in the 4th quarter in Fiscal 2009 and in Fiscal 2010.
- Chandler: The company’s Southern Plains Medical Group
subsidiary expects to benefit from its new relationship with Chandler
Medical Group. Chandler Medical Group provides an excellent source and
destination for quality care in the company’s rural Oklahoma network
near the company’s Stroud Regional Medical Center. The Chandler
acquisition is expected to add a positive contribution to revenue and
EBITDA in its first full year as part of TIGroup with initial impact
during fourth quarter Fiscal 2009.
- Liberty Hospital LOI: TIGroup signed a Letter of Intent (LOI)
with Liberty County Hospital District Number One and Frontier
Healthcare Group to acquire a controlling interest in the Liberty-Dayton
Community Hospital in Southeastern Texas and to develop a new
medical facility to serve the region. The closing of the transaction
is subject to due diligence, completion of definitive agreements,
financing and regulatory approvals. The current facility serves a
geographic area with population demographics equivalent to 80% of
TIGroup’s current service areas in rural Oklahoma.
- SPMC Refinancing: The refinancing and sale/leaseback of this
building, property and equipment is proceeding as the company works
with existing lenders on this new financing package with a goal of a
September 2009 closing, which, however, could slip into the fourth
calendar quarter.
- Management Additions: TIGroup expanded its management team with
the hiring of Dan Chen as Managing Director, Corporate Development of
TIGroup, Inc. based in the company’s headquarters in Beverly Hills,
California. Dan brings over 10 years of M&A, private equity and
operational experience to the team having worked at Texas Pacific
Group / Newbridge Capital (now known as TPG Asia) in San Francisco, at
Merrill Lynch & Co., Inc. in their M&A group in New York and San
Francisco, and at Montgomery & Co., LLC, a boutique investment bank in
Los Angeles.
TIGroup Chairman and CEO David Hirschhorn said, “This was an
event-filled quarter with an important number of developments including
our planned expansion into southeastern Texas with the agreements in
Liberty-Dayton, the addition of new physicians to our Del Mar facility,
creation of our advisory board and the expansion of our management team. “While it has taken a significant amount of time and expense to move
these matters forward, these investments are expected to show positive
results in our fourth quarter of fiscal year 2009 and into our new
fiscal year 2010,” Hirschhorn said.
Highlights from operating results for the third fiscal quarter were:
- Revenue from medical services for the third fiscal quarter totaled
$9.2 million. This represented an increase of 9.5% from $8.4 million
for the three-month period ended June 30, 2008.
- Revenue from medical services totaled $30.2 million for the nine
months of the fiscal year. This represented an increase of 53.3% from
$19.7 million for the comparable period ended June 30, 2008.
- The company-wide operating loss before non-cash charges for the
quarter ended June 30, 2009 was ($2.7 million) compared to operating
loss of ($1.4 million) for the period ending June 30, 2008. For the
current nine months the operating loss was ($4.5 million) versus
operating loss of ($2.0 million) for the comparable period ending June
30, 2008. Adjusted company-wide EBITDA was negative ($1.8 million)
reflecting the add-back of non-cash stock-based compensation,
depreciation/amortization, interest and non-cash beneficial conversion
feature preferred dividend to the overall net loss of ($3.7 million).
- The company retained a position of $4.1 million in available and
restricted cash.
- Bad Debt. The company took a conservative position on its bad debt
exposure by increasing reserves reflecting general economic conditions
and trends in the markets it operates in.
Hirschhorn added, “To better facilitate comparisons from reporting
period to reporting period on the productivity of our healthcare
facilities operations a non-GAAP supplemental chart is provided below.
These financials reconcile to our GAAP SEC filed results. We wanted to
highlight for investors and partners:
- Net revenues;
- EBITDA generated by our healthcare facilities;
- Bad debt trends which is a key industry statistic;
- SPMG overhead, our corporate operating subsidiary headquartered in
Oklahoma City; and
- TIGroup overhead, our corporate holding company
“We have made very significant investments in assembling our management
team, systems, deal making, due diligence, transaction processing and
financing methodology. We are comfortable that we can increase our
healthcare facility business volumes both organically and through
acquisitions without any significant further increases in our corporate
overhead. Our business platform is in place and our future growth via
internal operating improvements or the completion of new transactions
should add positively to our bottom line without commensurate increases
in overhead,” Hirschhorn said.
| Tri-Isthmus Group, Inc. |
| ($ in thousands) |
|
|
|
|
|
Quarter-Ended |
|
Nine Months Ended |
|
|
June 30, 2009 |
|
June 30, 2008 |
|
June 30, 2009 |
|
June 30, 2008 |
| Net Revenue From Services |
|
$ |
9,195 |
|
|
$ |
8,403 |
|
|
$ |
30,196 |
|
|
$ |
19,660 |
|
| Adjusted EBITDA From Operations |
|
|
| Healthcare Facilities |
|
$ |
1,203 |
|
|
$ |
1,646 |
|
|
$ |
6,576 |
|
|
$ |
4,067 |
|
| Bad Debts |
|
|
(1,199 |
) |
|
|
(822 |
) |
|
|
(3,330 |
) |
|
|
(1,621 |
) |
| SPMG Corporate Expense - Operating Company |
|
|
(721 |
) |
|
|
(688 |
) |
|
|
(2,588 |
) |
|
|
(1,562 |
) |
| TIGroup Corporate Expense |
|
|
(1,025 |
) |
|
|
(935 |
) |
|
|
(2,622 |
) |
|
|
(1,744 |
) |
| Adjusted EBITDA From Operations |
|
|
(1,742 |
) |
|
|
(799 |
) |
|
|
(1,964 |
) |
|
|
(860 |
) |
| Non-Cash Charges and Other: |
|
|
| Interest Income |
|
|
(131 |
) |
|
|
(187 |
) |
|
|
(229 |
) |
|
|
(261 |
) |
| Interest Expense |
|
|
837 |
|
|
|
201 |
|
|
|
1,449 |
|
|
|
709 |
|
| Depreciation & Amortization |
|
|
286 |
|
|
|
180 |
|
|
|
788 |
|
|
|
339 |
|
| Amortization Of Stock Based Compensation |
|
|
471 |
|
|
|
56 |
|
|
|
988 |
|
|
|
136 |
|
| Preferred Dividend (BCF) |
|
|
317 |
|
|
|
1,147 |
|
|
|
317 |
|
|
|
2,668 |
|
| Restructure (Severance) |
|
|
110 |
|
|
|
- |
|
|
|
439 |
|
|
|
- |
|
| Minority Interest Expense (Income) |
|
|
(37 |
) |
|
|
(240 |
) |
|
|
199 |
|
|
|
(71 |
) |
| Impairment Expense |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| (Gain) Loss on Sale of Investments |
|
|
- |
|
|
|
- |
|
|
|
281 |
|
|
|
- |
|
| One-time Charges |
|
|
- |
|
|
|
50 |
|
|
|
- |
|
|
|
50 |
|
| Contingent Payments to Physicians Related to Purchase Agreement |
|
|
100 |
|
|
|
- |
|
|
|
263 |
|
|
|
- |
|
| Closed facility expense |
|
|
14 |
|
|
|
264 |
|
|
|
36 |
|
|
|
606 |
|
| Net Income (Loss) |
|
$ |
(3,709 |
) |
|
$ |
(2,270 |
) |
|
$ |
(6,495 |
) |
|
$ |
(5,036 |
) |
About Tri-Isthmus Group, Inc. Tri-Isthmus Group, Inc. (TIGroup) is a financial solutions provider
focused on healthcare services operations designed to deliver quality
healthcare outside of traditional urban hospital settings. The company
is building a portfolio of interests in ambulatory surgical centers,
rural hospitals, surgical hospitals and other centers operating in
partnership with physicians. For more information, visit http://www.tig3.com. A profile for investors can be accessed at http://www.hawkassociates.com/profile/tisg.cfm.
An online investor kit including press releases, current price quotes,
stock charts and other valuable information for investors is available
at http://www.hawkassociates.com.To
receive free e-mail notification of future releases for TIGroup, sign up
at http://www.hawkassociates.com/about/alert/.
Safe-Harbor Statement under the Private Securities Litigation Reform
Act of 1995: This press release may contain forward-looking
information within the meaning of Section 21E of the Securities Exchange
Act of 1934, as amended (the” Exchange Act”), including all statements
that are not statements of historical fact regarding the intent, belief
or current expectations of the company, its directors or its officers
with respect to, among other things: (i) the company’s financing plans;
(ii) trends affecting the company’s financial condition or results of
operations; (iii) the company’s growth strategy and operating strategy;
and (iv) the declaration and payment of dividends. The words “may,”
“would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend”
and similar expressions and variations thereof are intended to identify
forward-looking statements. Investors are cautioned that any such
forward-looking statements are not guarantees of future performance and
involve risks and uncertainties, many of which are beyond the company’s
ability to control, and that actual results may differ materially from
those projected in the forward-looking statements as a result of various
factors including the risk disclosed in the company’s Forms 10-K and
10-Q filed with the SEC.